期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 288, 期 4, 页码 2246-2260出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112.375253
关键词
-
资金
- Swiss National Science Foundation
- Muscular Dystrophy Association USA (MDA)
- SwissLife Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung
- Swiss Society for Research on Muscle Diseases (SSEM)
- Swiss Diabetes Association
- Roche Research Foundation
- United Mitochondrial Disease Foundation (UMDF)
- Association Francaise contre les Myopathies (AFM)
- Gebert-Ruf Foundation Rare Diseases Program
- University of Basel
A persistent, low-grade inflammation accompanies many chronic diseases that are promoted by physical inactivity and improved by exercise. The beneficial effects of exercise are mediated in large part by peroxisome proliferator-activated receptor gamma coactivator (PGC) 1 alpha, whereas its loss correlates with propagation of local and systemic inflammatory markers. We examined the influence of PGC-1 alpha and the related PGC-1 beta on inflammatory cytokines upon stimulation of muscle cells with TNF alpha, Toll-like receptor agonists, and free fatty acids. PGC-1s differentially repressed expression of proinflammatory cytokines by targeting NF-kappa B signaling. Interestingly, PGC-1 alpha and PGC-1 beta both reduced phoshorylation of the NF-kappa B family member p65 and thereby its transcriptional activation potential. Taken together, the data presented here show that the PGC-1 coactivators are able to constrain inflammatory events in muscle cells and provide a molecular link between metabolic and immune pathways. The PGC-1s therefore represent attractive targets to not only improve metabolic health in diseases like type 2 diabetes but also to limit the detrimental, low-grade inflammation in these patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据